There are menopause symptoms that women talk about openly. Hot flashes. Brain fog. Weight gain. These have entered the cultural conversation enough that women feel comfortable naming them — to their doctors, to their friends, sometimes publicly. Then there are the symptoms that stay private. That women carry alone because they do not know how to start the conversation or whether anyone will take it seriously or whether something can even be done. Vaginal dryness is one of those symptoms. It affects more than half of all women during and after menopause. It causes physical discomfort every day, pain during intimacy, and changes to relationships and self-image that women rarely describe to anyone. And it is consistently undertreated — not because there is nothing to be done but because women are not told that there is. This article exists to close that gap.

What Is Actually Happening

The vaginal tissue is estrogen-dependent. Estrogen maintains the health, thickness, elasticity, and lubrication of the vaginal walls. It supports the production of vaginal secretions that keep the tissue moist, resilient, and resistant to irritation and infection. When estrogen declines the vaginal tissue undergoes a gradual process of change called the genitourinary syndrome of menopause — a clinical term that encompasses the full range of changes to the vagina, vulva, and urinary tract caused by estrogen loss. The vaginal walls become thinner and less elastic. Lubrication decreases. The pH of the vaginal environment changes — becoming less acidic and more vulnerable to bacterial overgrowth and infection. The tissue becomes more fragile and more easily irritated. The result is dryness, itching, burning, and discomfort that can range from a persistent background irritation to significant pain that affects daily functioning. Intimacy becomes uncomfortable or painful. The changes to the vaginal environment increase the frequency of urinary tract infections and may contribute to urinary urgency and incontinence. Unlike hot flashes — which for many women diminish over time even without treatment — the genitourinary syndrome of menopause does not improve without intervention. It typically worsens progressively without estrogen support.

Why It Goes Untreated

The gap between how common this condition is and how often it is treated is one of the most significant failures in women's healthcare. Part of the reason is embarrassment. Women do not always feel comfortable describing vaginal symptoms to their doctor — particularly in a brief appointment where they may already feel dismissed for other concerns. The cultural discomfort around discussing intimate health means that women often minimize what they are experiencing or do not mention it at all. Part of the reason is that doctors do not always ask. A routine appointment focused on blood pressure and cholesterol does not typically include a conversation about vaginal health changes unless the patient raises it. And the patient often does not raise it. Part of the reason is that women do not know treatment exists or how effective it is. Vaginal dryness is frequently accepted as an unavoidable consequence of aging — something to be managed with over- the-counter lubricants and simply endured. The availability of highly effective prescription treatments is not widely communicated. Part of the reason is that HRT conversations often focus on systemic symptoms — hot flashes, sleep, mood — without specifically addressing the genitourinary component. Even women on systemic HRT are not always told that local vaginal estrogen may provide additional targeted benefit for vaginal symptoms specifically.

What Treats It — The Options

There are several effective treatment options for vaginal dryness and the genitourinary syndrome of menopause. They range from over-the-counter options that provide symptomatic relief to prescription treatments that address the underlying tissue change. Over-the-counter lubricants and moisturizers provide symptomatic relief. Lubricants reduce friction during intimacy. Vaginal moisturizers used regularly can help maintain tissue hydration between episodes of dryness. These do not treat the underlying tissue changes caused by estrogen loss but they can meaningfully reduce discomfort and are appropriate as part of a broader management approach. Systemic HRT — estradiol patches, gels, or oral tablets — improves vaginal health as part of its broader hormonal effect. For women on adequate systemic HRT vaginal symptoms often improve significantly. However systemic HRT at the doses typically used for vasomotor symptoms does not always provide sufficient estrogen to the vaginal tissue to fully address genitourinary symptoms — which is why local treatment is often recommended in addition. Local vaginal estrogen is the most targeted and effective treatment for the genitourinary syndrome of menopause. It is available in several forms — vaginal cream, vaginal insert, vaginal ring, and vaginal tablet — each delivering low-dose estradiol directly to the vaginal tissue. Because local vaginal estrogen is delivered directly to the tissue rather than absorbed systemically the amount entering the bloodstream is minimal. This makes it appropriate for many women who have concerns about systemic HRT — including some women with a history of hormone-sensitive cancer, though this always requires individual clinical assessment. Vaginal DHEA — available as a vaginal insert — is metabolized locally into both estrogen and testosterone within the vaginal tissue. It is an effective option for women who prefer or require an alternative to direct estrogen. Ospemifene is an oral selective estrogen receptor modulator that acts on vaginal tissue without being a traditional estrogen. It is an option for women who prefer not to use vaginal preparations.

How Quickly It Works

Local vaginal estrogen typically produces noticeable improvement within two to four weeks of consistent use. Tissue thickness and elasticity improve more gradually — over six to twelve weeks of regular treatment. The changes to vaginal pH that reduce infection risk also improve over this longer timeframe. For most women the improvement with appropriate treatment is significant. Pain during intimacy that was affecting their relationship resolves. The daily background discomfort lifts. The frequency of UTIs decreases. Treatment is typically ongoing. Unlike systemic HRT which some women use for a defined period local vaginal estrogen is generally used indefinitely because the underlying cause — estrogen deficiency in the vaginal tissue — does not resolve on its own. Stopping treatment typically means symptoms return.

The Intimacy Conversation

The impact of vaginal dryness on intimacy — and therefore on relationships — is significant and rarely discussed openly. Pain during sex leads to avoidance. Avoidance leads to distance. Distance leads to misunderstanding between partners who may not know what is causing the change. Women frequently describe feeling guilty or inadequate. Partners frequently describe confusion and worry. The relationship suffers from a symptom that neither person knows how to name or address. This is not inevitable. It is the consequence of a condition that is not being treated — usually because it is not being discussed. Effective treatment of vaginal dryness restores comfortable intimacy for the vast majority of women who use it consistently. This is not a side effect of treatment. It is the point. You are allowed to want intimacy to feel comfortable. You are allowed to expect that menopause does not have to permanently change that part of your life. You are allowed to ask for treatment that addresses it.

How To Bring It Up With Your Doctor

If you have not yet raised this with a doctor because you were not sure how — here is the simplest way to start the conversation. Tell your doctor you are experiencing vaginal dryness and discomfort that you believe is related to menopause and you would like to discuss treatment options. That is enough. You do not need to describe it in more detail than you are comfortable with. You do not need to minimize it or apologize for raising it. You do not need to be certain of the cause before you ask. A menopause-literate physician will take it from there. They will ask the relevant follow-up questions, assess the severity, and discuss the treatment options that are appropriate for your individual situation and history. If your doctor dismisses it or tells you to simply use lubricant and says nothing more — that is not a complete clinical response to a treatable condition. You are entitled to more information and more options.

Final Thoughts

You should not have to live with daily discomfort because a symptom felt too private to discuss. You should not have to accept that intimacy is now painful because nobody told you there was something that could help. You should not be managing a progressive and treatable condition with over-the-counter products alone because your doctor never raised the prescription options. Vaginal dryness during menopause is common. It is real. It is significant. And it is highly treatable with the right clinical support. You deserve to know that. You deserved to know it sooner. And you deserve a doctor who will actually talk to you about it.